Comparative effectiveness of tocilizumab and TNF inhibitors in rheumatoid arthritis patients

Objectives. To compare the effectiveness of TNF inhibitors (TNFi) and tocilizumab in rheumatoid arthritis (RA) treatment, according to different response criteria. Methods. We included RA patients registered in the Rheumatic Diseases Portuguese Register treated with TNFi or tocilizumab for at least...

ver descrição completa

Detalhes bibliográficos
Autor principal: Romão, Vasco C. (author)
Outros Autores: Santos, Maria José (author), Polido-Pereira, Joaquim (author), Duarte, Cátia (author), Nero, Patrícia (author), Miguel, Cláudia (author), Costa, José António (author), Bernardes, Miguel (author), Pimentel-Santos, Fernando M. (author), Barcelos, Filipe (author), Costa, Maria Lúcia (author), Melo Gomes, José António (author), Pereira Da Silva, José Alberto (author), Branco, Jaime da Cunha (author), Canas da Silva, José (author), Pereira Da Silva, José António (author), Fonseca, João Eurico (author), Canhão, Helena (author), Shi, Guixiu (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
INTERLEUKIN-6 RECEPTOR INHIBITION
DRUG SURVIVAL
DOUBLE-BLIND
ADALIMUMAB
REMISSION
EFFICACY
TRIAL
ETANERCEPT
INFLIXIMAB
SAFETY
Immunology and Microbiology(all)
Biochemistry, Genetics and Molecular Biology(all)
Texto completo:https://doi.org/10.1155/2015/279890
País:Portugal
Oai:oai:run.unl.pt:10362/21947

Texto Completo

https://doi.org/10.1155/2015/279890

Registros relacionados